PHIA Koninklijke Philips N.V.

Philips debuts new emergency care informatics suite in U.S. market at HIMSS 2020

Philips debuts new emergency care informatics suite in U.S. market at HIMSS 2020

March 3, 2020

  • Now with FDA 510(K) clearance, web-based dashboard supports real-time data transfer to empower clinical decision-making in emergency care
  • Enhanced bidirectional feedback between first responders in the field and clinicians in the hospital helps improve patient care

Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the U.S. launch of its pre-hospital informatics solution to provide real-time, bidirectional feedback between emergency responders on the scene and doctors in the hospital awaiting the arrival of the patient. The combination of Philips’ rugged, advanced vital signs monitor and its new emergency care informatics web-based dashboard enables emergency teams to capture and transmit clinical data to remote specialists, allowing the team at the hospital to immediately review a patient’s vitals and plan for their arrival. The solution aims to help emergency responders provide the best care possible in unpredictable pre-hospital environments.

Evolving EMS role currently outpacing evolving technology

The role of Emergency medical services (EMS) has evolved drastically, as they now face both clinical and operational challenges in trying to address the needs of patients. Caregivers experience unpredictable workloads in uncontrolled situations with the expectation they will diagnose, treat and transport patients where necessary. Challenges are exacerbated by lagging technological advancements, particularly in relation to flexibility of use and data acquisition. Monitors and defibrillators are typically bulky and heavy, while data collection remains a predominantly manual and retrospective process. Data automation and more reliable communication capabilities, paired with smaller and lighter monitors, can empower emergency responders to provide care closer to home, avoid unnecessary transports, and better allocate resources, helping to achieve the quadruple aim of improved outcomes, enhanced satisfaction for caregivers and patients, and reduced costs.

“Emergency medical service personnel are increasingly sharing that the rising demands placed on first responders coupled with the challenging and diverse cases they see require improved technology to meet patient needs,” said Arman Voskerchyan, General Manager for Therapeutic Care at Philips. “Emergency care is no longer just about resuscitation – there are higher incidences of cardiovascular disease, increasing co-morbidities, and a rapidly growing aging population. With these changes, EMS providers need better access to data and resources to help them adapt and equip them with the information needed to save lives.”

Making its debut in the U.S. at HIMSS 2020, the solution has already been in use in Europe, helping care teams spot life-threatening conditions remotely, improve accuracy of support from on-scene crews, and enhance tailoring of in-hospital care based on pre-hospital physiology.

Philips Portfolio in Emergency Care

In October 2019, Philips where helicopter Emergency Service (HEMS) teams were able to live stream patient medical information from the scene to the hospital through the Philips pre-hospital solution. Philips offers a range of emergency care offerings, including automated external defibrillators (AEDs), advanced life support monitors, and more.

For more information on Philips’ full portfolio of integrated smart enterprise systems, devices, software and services that will be spotlighted in Booth #2701 at the HIMSS Global Conference & Exhibition in Orlando, FL, Mar. 9 -13, 2020, visit and follow for #HIMSS2020 updates throughout the event.

For further information, please contact:

Kathy O’Reilly

Philips Global Press Office

Tel.:

E-mail:

Twitter:

Silvie Casanova

Philips North America

Tel:

Email:

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 80,000 employees with sales and services in more than 100 countries. News about Philips can be found at .

Attachments

EN
03/03/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

 PRESS RELEASE

Philips agrees to acquire SpectraWAVE Inc., advancing next-generation ...

Philips agrees to acquire SpectraWAVE Inc., advancing next-generation coronary intravascular imaging and physiological assessment with AI December 15, 2025 Acquisition of SpectraWAVE’s next-generation technologies including HyperVueTM Imaging System with Enhanced Vascular Imaging for comprehensive, rapid, and AI-supported imaging inside the coronary arteries, and X1TM-FFR, an AI-enabled angio-based FFR technology that delivers rapid, accurate coronary physiology assessment from a single angiogram [1] SpectraWAVE’s technologies have the potential to significantly increase adoption of corona...

 PRESS RELEASE

Philips reiterates timing of 2026 outlook

Philips reiterates timing of 2026 outlook December 4, 2025 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today reaffirmed that its 2026 outlook will be issued as planned on February 10, in line with the company’s previously communicated schedule. As previously guided, the company expects continued performance improvement with sequential comparable sales growth, expanded margins (despite tariff headwinds) and strong cashflow. The company continues to expect comparative sales growth to accelerate sequentially in 2026 towards mid-single-digit gro...

 PRESS RELEASE

Philips expands commercial availability of world’s first real-time AI-...

Philips expands commercial availability of world’s first real-time AI-enabled light-based 3D navigation solution for image-guided therapy December 1, 2025 Commercial availability expanded across Europe and the United StatesReal-time AI-enabled 3D device visualization powered by light instead of X-ray, improving navigation in complex endovascular proceduresLumiGuide seamlessly integrates with Azurion, Philips’ proven, world-leading image-guided therapy platform designed to drive procedural innovation across clinical domains Amsterdam, the Netherlands and Chicago, USA – (NYSE: PHG, AEX: PH...

 PRESS RELEASE

Philips launches Verida, world’s first detector-based spectral CT powe...

Philips launches Verida, world’s first detector-based spectral CT powered by breakthrough AI, to advance diagnostic precision November 30, 2025 Philips pioneered detector-based spectral CT, which has been widely adopted in clinical routine exams across anatomies, supported by over 800 peer-reviewed publications [1]CE-marked, 510k pending Verida CT [2] integrates AI across the imaging chain, providing superb image quality while accelerating workflow and reducing dose [3, 4] Amsterdam, the Netherlands and Chicago, USA – At RSNA 2025, (NYSE: PHG, AEX: PHIA), a global leader in health techno...

 PRESS RELEASE

Philips unveils BlueSeal Horizon, industry’s first helium-free 3.0T MR...

Philips unveils BlueSeal Horizon, industry’s first helium-free 3.0T MRI platform November 30, 2025 Major technology breakthrough combines advanced AI for clinical insights and accelerated workflow in new premium 3.0T MRI platform [1] Amsterdam, the Netherlands, and Chicago, USA – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled BlueSeal Horizon [1], an entirely new 3.0T MRI innovation platform that includes the industry’s first helium-free 3.0T magnet at . A pivotal advance in MRI innovation, helium-free [2] 3.0T is a major scientific achievement set to have s...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch